Elevation Wealth Partners’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.2K Buy
319
+305
+2,179% +$25.9K 0.01% 508
2026
Q1
$1.21K Buy
14
+10
+250% +$898 ﹤0.01% 978
2025
Q4
$350 Hold
4
﹤0.01% 924
2025
Q3
$230 Buy
+4
New +$230 ﹤0.01% 852
2024
Q3
Sell
-35
Closed -$2.4K 508
2024
Q2
$2.4K Buy
+35
New +$2.09K ﹤0.01% 443

Other funds holding GMED

Elevation Wealth Partners's GMED Position: Q2 2026 in Review

Elevation Wealth Partners increased its Globus Medical (GMED) stake by 2,179% in Q2 2026, buying an estimated $25.9K and bringing the position to 319 shares worth $25.2K. The position accounts for 0.01% of the portfolio, ranked #508.

Elevation Wealth Partners first reported a position in GMED in Q2 2024 and has held it in 5 quarters since. 62 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Elevation Wealth Partners held 319 shares of Globus Medical worth $25.2K as of Q2 2026.
  • Elevation Wealth Partners bought 305 Globus Medical shares in Q2 2026, an estimated $25.9K.
  • Globus Medical made up 0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #508 holding.
  • Elevation Wealth Partners first reported a position in Globus Medical in Q2 2024 and has held it in 5 quarters since.
  • 62 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.